STAT

Opinion: You can’t pay for 21st century medicines with a 20th century payment system

The U.S. pays for 21st-century drugs with a 20th-century payment system. It's like using a 1999 road atlas in the era of Google Maps.

Many Americans are angry and worried about the price of prescription drugs. Yet underneath the anecdotes and headlines, a deeper, more consequential issue is often ignored. A major transformation in the drug industry has occurred in recent years — and continues today. The science and economics of the pharmaceutical industry have fundamentally changed, but the way we pay for medicines has not.

We essentially have 21st-century drugs with a 20th-century payment system. It’s like using a 1999 road atlas in the era of Google

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: No, Alcohol Isn’t Good For You. Will New Dietary Guidelines Be Shaped More By Health Or Industry Interests?
More and more studies show that alcohol isn't healthy after all. Dietary guidelines are up for revision in 2025, and already, there's debate over research and industry influence.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT1 min read
STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.

Related Books & Audiobooks